[Purulent pericarditis due to Salmonella enterica subsp. arizonae].
Salavert
Miguel
M
Navarro
Vicente
V
Roig
Pablo
P
D000583:Amikacin / Q000627:therapeutic use; D000818:Animals; D000829:Animals, Domestic / Q000382:microbiology; D001281:Atrial Fibrillation / Q000209:etiology; D002444:Cefuroxime / Q000627:therapeutic use; D002939:Ciprofloxacin / Q000627:therapeutic use; D003131:Combined Modality Therapy; D004359:Drug Therapy, Combination / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D009784:Occupational Diseases / Q000150:complications / Q000188:drug therapy / Q000382:microbiology* / Q000601:surgery; D016273:Occupational Exposure; D020519:Pericardiocentesis; D010493:Pericarditis / Q000150:complications / Q000188:drug therapy / Q000382:microbiology* / Q000601:surgery; D012480:Salmonella Infections / Q000150:complications / Q000188:drug therapy / Q000382:microbiology* / Q000601:surgery; D012476:Salmonella arizonae / Q000302:isolation & purification*; D013492:Suppuration; D014730:Veterinary Medicine
D002939:Ciprofloxacin; D000583:Amikacin; D002444:Cefuroxime